Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of this study is to look for the presence of SARS-CoV-2 in the semen of patients diagnosed with COVID+ based on RT-PCR analysis of nasopharyngeal swabs.
This is a prospective monocentric, open-label, prospective study of male patients with CoV-2-SARS.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| COHORT | Experimental | Cohort |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| diagnostic | Diagnostic Test | The principle of this study is to propose to patients in whom a COVID-19 infection is suspected and who are screened for the disease, the joint search for the virus in the semen. |
| Measure | Description | Time Frame |
|---|---|---|
| Testing for the presence of COVID-19 (SARS-CoV-2 virus) in the semen | The search for the SARS-CoV-2 virus in semen will be carried out by RT-PCR analysis with the RealStar kit developed by Altona Diagnostics. The extraction of the nucleic acid suitable for sperm uses the Pure MagNA technique (Diagnostics ROCHE). This is an extraction technique that has already been validated for HIV-type RNA viruses in semen. The biological samples will be analysed either during the study or bio-banked and analysed at the end of the study. Only semen samples from patients detected positive for SARS-CoV-2 by RT-PCR on nasopharyngeal swab will be analyzed. | 48 hours |
| Kinetics of SARS-CoV-2 virus presence in the semen | Patients who have been found to carry the SARS-CoV-2 virus in their semen will be recalled after one month to re-test for the virus. In case of a positive re-test, a new search will be scheduled and so on until a negative result is found. | 1 month |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Semen collection
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lucie DELAROCHE, Pharm D | Hôpital privé de Parly II | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Privé de Parly II | Le Chesnay | 78150 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
This is a prospective monocentric, open-label, prospective study of male patients with CoV-2-SARS.
Not provided
Not provided
Not provided
Not provided